Fed. Circ. Won't Revive Vanda's Sleep Disorder Patent Claims
The Federal Circuit has backed a district judge's opinion wiping out four Vanda patents on brand-name treatment Hetlioz in an infringement battle with Teva and Apotex over planned generics, agreeing that...To view the full article, register now.
Already a subscriber? Click here to view full article